Brown Advisory Inc Jounce Therapeutics, Inc. Transaction History

Brown Advisory Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$7.27 - $21.88 $3.57 Million - $10.7 Million	-490,541 Closed	0 $0
Q1 2018 Jun 28, 2018	BUY	$13.4 - $28.4 $2.71 Million - $5.75 Million	202,491 Added 70.3%	490,541 $11 Million
Q1 2018 May 14, 2018	SELL	$13.4 - $28.4 $2.73 Million - $5.78 Million	-203,479 Reduced 41.4%	288,050 $6.44 Million
Q4 2017 Feb 12, 2018	BUY	$12.52 - $17.82 $197,941 - $281,734	15,810 Added 3.32%	491,529 $6.27 Million
Q3 2017 Nov 13, 2017	BUY	$11.17 - $16.99 $1.91 Million - $2.9 Million	170,661 Added 55.94%	475,719 $7.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	305,058	305,058 $4.28 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.